The Origin of the Plasma Cell Heterogeneity
Plasma cells (PCs) are terminally differentiated B-cells producing large amounts of immunoglobulins (Ig). In humans, most of circulating Ig are produced by bone marrow plasma cells. PCs differentiate from activated naïve or memory B-cells usually activated by specific antigens. It is still controve...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Book Chapter |
Published: |
Frontiers Media SA
2015
|
Subjects: | |
Online Access: | Get Fullteks DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 02266naaaa2200349uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_55432 | ||
005 | 20210211 | ||
020 | |a 978-2-88919-734-7 | ||
020 | |a 9782889197347 | ||
024 | 7 | |a 10.3389/978-2-88919-734-7 |c doi | |
041 | 0 | |a English | |
042 | |a dc | ||
100 | 1 | |a Thierry Defrance |4 auth | |
700 | 1 | |a Catherine Pellat-Deceunynck |4 auth | |
245 | 1 | 0 | |a The Origin of the Plasma Cell Heterogeneity |
260 | |b Frontiers Media SA |c 2015 | ||
300 | |a 1 electronic resource (80 p.) | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Plasma cells (PCs) are terminally differentiated B-cells producing large amounts of immunoglobulins (Ig). In humans, most of circulating Ig are produced by bone marrow plasma cells. PCs differentiate from activated naïve or memory B-cells usually activated by specific antigens. It is still controversial whether the regulation of PCs numbers and the "active" in vivo Ig diversity depend or not on non-specific reactivation of B-cells during infections. Depending on the stimulus (T-independent/T-dependent antigen, cytokines, partner cells) and B-cell types (naïve or memory, circulating or germinal center, lymph nodes or spleen, B1 or B2...), both the phenotype and isotype of PCs differ suggesting that PC diversity is either linked to B-cell diversity or to the type of stimulus or to both. Knowledge of the mechanisms supporting PC diversity has important consequences for the management of i) plasma cell neoplasia such as Multiple Myeloma and Waldenström's Macroglobulinemia, ii) vaccine protection against pathogens and iii) auto-immune diseases. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
653 | |a IL21 | ||
653 | |a Autoimmunity | ||
653 | |a differentiation | ||
653 | |a Cell Cycle | ||
653 | |a B-cell | ||
653 | |a Plasma cell | ||
653 | |a Myeloma | ||
653 | |a Autophagy | ||
653 | |a B1 | ||
856 | 4 | 0 | |a www.oapen.org |u http://journal.frontiersin.org/researchtopic/1504/the-origin-of-the-plasma-cell-heterogeneity |7 0 |z Get Fullteks |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/55432 |7 0 |z DOAB: description of the publication |